Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Carmen Kreft Jaïs"'
Publikováno v:
Substance Use & Misuse. 49:1633-1645
Important social changes such as urbanization, increases in female education and employment, and increased incomes have occurred in France from 1960 to 2000 along with a major decrease in alcoholic beverage consumption (from 25 L pure alcohol per inh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81343e2907523d92a14d007c5bcd1a58
https://doi.org/10.3109/10826084.2014.913391
https://doi.org/10.3109/10826084.2014.913391
Autor:
Florence Tubach, Véronique Lamarque-Garnier, Anne Castot, Laurent Auclert, Marthe Bonnin, Magda Daudin, Catherine Dubois, Alain Francillon, Elisabeth Frauger, Danièle Girault, Marie-Laurence Gourlay, Pascale Jolliet, Carmen Kreft Jaïs, Lamiae Grimaldi, Michel Lièvre, Patricia Maillère, Philippe Maugendre, Joelle Micallef, Sara Miranda, Antoine Pariente, Sylvie Paulmier Bigot, Jonathan Pentel, Laure Prestat, Fanny Pruvot, Valérie Querol Ferrer, Fanny Rocher, Christel Saussier, Laura Zanetti
Publikováno v:
Therapies. 66:347-354
Resume Les etudes realisees apres l’autorisation de mise sur le marche (AMM) ayant pour objectif d’identifier, caracteriser ou quantifier un ou des risques, appelees Post-authorization safety studies (PASS), ont ete renforcees ces dernieres annee
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4eb355074173b0f8ad3993825df7260f
https://doi.org/10.2515/therapie/2011041
https://doi.org/10.2515/therapie/2011041
Publikováno v:
Clinical Medicine Reviews in Therapeutics. 3:355-369
Everolimus (ERL) is a recently developed mTOR inhibitor. This rapamycin analog is used to prevent acute rejection during kidney and heart transplantation. We review here published clinical trials and experiences concerning potential applications of E
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0846f63c8043bb0f7caeed0956bb6310
https://doi.org/10.4137/cmrt.s1550
https://doi.org/10.4137/cmrt.s1550
Autor:
Véronique Lamarque, Louis Merle, Jean Paul Demarez, Haleh Bagheri, Arnaud Biraben, Jean-Paul Fagot, Jean-Dominique Hamel, Carmen Kreft-Jaïs, Françoise Haramburu, Marie-Laure Laroche, Hervé Le Louet, Claire Martray, Jacques Mascaro, Christian Pisano, Myriam Rosilio, Franck Rouby, Alain Saint-Pierre, Éric Singlas
Publikováno v:
Therapies. 63:301-309
Resume L’utilisation des generiques est generatrice d’economies pour le budget de l’assurance maladie, et aucun acteur de sante ne pourrait en remettre serieusement en cause le principe. Le medicament generique d’une specialite de reference s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f5e0f3cdca4d54f7b7eeb4cc66a0aaf3
https://doi.org/10.2515/therapie:2008044
https://doi.org/10.2515/therapie:2008044
Publikováno v:
Journal of Alzheimer's disease : JAD. 47(2)
Background: The negative image surrounding AD has a substantial impact on caregiving and on those affected by the disease. Opinion surveys were created as part of the 2008–2012 Alzheimer Plan in France, which included two surveys of the general pop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ff03851131127271c4305b14f21587f
https://pubmed.ncbi.nlm.nih.gov/26401568
https://pubmed.ncbi.nlm.nih.gov/26401568
Autor:
Carmen Kreft-Jaïs, Pierre Arwidson
Publikováno v:
Global Health Promotion. 20:110-112
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cc3e149df509b0662b12eb52c4580ad0
https://doi.org/10.1177/1757975913485688
https://doi.org/10.1177/1757975913485688
Autor:
Pierre Arwidson, Carmen Kreft-Jaïs
Publikováno v:
Global Health Promotion. 20:5-7
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e54b54270feb4cf4235868e39718ce95
https://doi.org/10.1177/1757975913485687
https://doi.org/10.1177/1757975913485687
Autor:
Pierre Arwidson, Carmen Kreft-Jaïs
Publikováno v:
Global Health Promotion. 20:63-65
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0c3cdd50fb22345373bd91e6d5c27b77
https://doi.org/10.1177/1757975913485686
https://doi.org/10.1177/1757975913485686
Autor:
Florence Tubach, Véronique Lamarque-Garnier, Anne Castot, Laurent Auclert, Marthe Bonnin, Magda Daudin, Catherine Dubois, Alain Francillon, Elisabeth Frauger, Danièle Girault, Marie-Laurence Gourlay, Pascale Jolliet, Carmen Kreft Jaïs, Lamiae Grimaldi, Michel Lièvre, Patricia Maillère, Philippe Maugendre, Joelle Micallef, Sara Miranda, Antoine Pariente, Sylvie Paulmier Bigot, Jonathan Pentel, Laure Prestat, Fanny Pruvot, Valérie Querol Ferrer, Fanny Rocher, Christel Saussier, Laura Zanetti
Publikováno v:
Therapie. 66(4)
Studies conducted after the marketing authorisation with the objective of identification, characterization or quantification of one or more risks (called PASS "Post-Authorisation Safety Studies"), have been strengthened in the past years with the imp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::777d06ee03dc503bbf34b4a129123b00
https://pubmed.ncbi.nlm.nih.gov/21851800
https://pubmed.ncbi.nlm.nih.gov/21851800
Publikováno v:
La Revue du praticien. 60(10)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::213ff51c894288fca9d0c9fa087584b8
https://pubmed.ncbi.nlm.nih.gov/21425536
https://pubmed.ncbi.nlm.nih.gov/21425536